Search This Blog

Wednesday, May 6, 2020

Cellular Biomedicine EPS beats by $0.16

Cellular Biomedicine (NASDAQ:CBMG): Q1 GAAP EPS of -$0.60 beats by $0.16.
Cash, equivalents and restricted cash of $21.6M (+40.3% Q/Q)
Press Release
https://seekingalpha.com/news/3570635-cellular-biomedicine-eps-beats-0_16
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)